Techsol Life Sciences Honored with Oracle Health and Life Sciences Industry Solutions Award 2025 at Oracle AI World

Global Strategic Partner accolade marks its Oracle partner award, reaffirming leadership in the Global Life Sciences Industry.

Las Vegas, NV, October 14, 2025: At the prestigious Partner Success Summit during Oracle AI World 2025, Techsol Life Sciences (Techsol) was officially named the winner of the Oracle Health and Life Sciences Industry Solutions Award 2025 in the Global Strategic Partner category. The award was conferred during a gala ceremony in Las Vegas on October 14, where leading global Oracle partners and industry stakeholders convened to celebrate innovation and excellence.

This marks the fifth time Techsol has earned top honors from Oracle in its partner awards program (previous awards were won in 2023, 2019 [two categories], and 2014). As a market leader focusing on the unique needs of life sciences organizations, Techsol implements end-to-end technology and technology integrated business process functional solutions across R&D, clinical development, regulatory, quality, pharmacovigilance, medical affairs, and commercial operations. Their offerings are deeply integrated with Oracle’s Health & Life Sciences industry applications, data, AI, and cloud stacks. Winning this award reaffirms Techsol’s ability to deliver transformative, Oracle-based solutions to some of the world’s most demanding life sciences clients. 

“We are immensely proud to receive this distinguished award from Oracle,” said Satya Sagi, CEO & Founder, Techsol. “This honor reflects the commitment, relentless focus, hard work of our teams over many years, deep domain insight in biopharma and medical device sectors, and continuous co-innovation with Oracle. It also strengthens our trajectory as we further scale offerings around AI-embedded R&D, precision data platforms, and commercialization solutions across global markets.”

Sriram Varma, Co-founder & SVP, Tech & Data Services Business Unit, Techsol, added: “This award is a tribute to our technical excellence and the deep synergy we have built with Oracle’s Health & Life Sciences market leading and superior application and cloud technology stack. From high-performance data platforms to Agentic AI supporting drug discovery, regulatory analytics, pharmacovigilance and post-market insights, our joint solutions are being adopted by leading innovators, emerging companies and large enterprises globally. We view this as both recognition and a mandate to push further, innovating faster, at greater scale, across complex life sciences challenges.”

At the Global Partnership Summit, Oracle also showcased emerging technology trends in health & life sciences, such as embedded AI within Oracle Health modules, real-world data analytics, safety signal detection, and interoperable platforms across the Oracle Cloud Infrastructure (OCI). Techsol’s winning solutions were spotlighted among finalists for their ability to integrate life sciences domain workflows with Oracle’s applications, AI, data, regulatory, and cloud frameworks.

This accolade further cements Techsol Life Sciences’ position as a premier strategic collaborator in the Oracle ecosystem, offering unique depth in the life sciences domain combined with cutting-edge technology delivery. Techsol will continue pushing the boundary of what is possible in biopharma, gene therapy, and medical device innovation powered by Oracle.

About Techsol Life Sciences
Techsol Life Sciences is a global solutions provider dedicated to accelerating innovation across biopharma, gene therapy, orphan drug, vaccine and medical device industries. Its platform suites cover R&D, regulatory, medical affairs, pharmacovigilance/safety, quality, and commercialization functions. Techsol partners with leading OEMs worldwide to deliver scalable, high-value, AI- and data-driven life sciences systems.